Related Experiment Video
Updated: Mar 1, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Concurrent intravenous drug administration to critically ill children: Evaluation of frequency and compatibility
Melany Gaetani1, Helena Frndova2, Winnie Seto3
1Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research & Learning [PGCRL], 686 Bay Street, 11th floor, Toronto, Ontario M5G 0A4, Canada.
Insights
Concurrent intravenous drug administration is common in critically ill children. While some drug-drug incompatibilities are known, many remain unknown, complicating patient care and highlighting research needs.
Area of Science:
- Pediatric Critical Care Medicine
- Clinical Pharmacy
- Pharmacology
Background:
- Critically ill children often receive multiple intravenous medications concurrently.
- Managing complex medication regimens in pediatric intensive care units (PICUs) presents significant challenges.
Purpose of the Study:
- To determine the frequency of concurrent intravenous drug administration in critically ill children.
- To assess the rate of drug-drug incompatibilities among concurrently administered medications in this population.
Main Methods:
- Retrospective analysis of intravenous drug administration in a single pediatric critical care center over a ten-year period.
- Inclusion criteria: patients admitted for at least 6 hours receiving two or more intravenous drug administrations.
- Drug compatibilities were evaluated using local reference documents.
Main Results:
- Over 16,800 patients received over 3.6 million concurrent administrations.
- Approximately 62% of administrations were concurrent, with only 9% confirmed compatible and 8% incompatible.
- A significant portion (21%) had unknown compatibility, and 8% required pharmacist consultation.
Conclusions:
- Concurrent intravenous drug administration is a frequent occurrence in critically ill children.
- Known drug-drug incompatibilities are present, but a substantial number of drug pairs have unknown compatibility.
- The high frequency of unknown compatibilities complicates bedside management and indicates a need for further research.
Purpose:
To evaluate the frequency of concurrent drug administration and drug-drug incompatibility of concurrently administered drugs in critically ill children based on available references.
Materials And Methods:
We retrospectively evaluated concurrent intravenous drug administration in children admitted to a single centre. Eligible patients included those admitted to the critical care unit for at least 6-hours in the ten-year period ending 30 July 2015 and received two or more IV drug administrations. Compatibilities were classified using local reference documents.
Results:
The 16,863 eligible patients were admitted to ICU for 2,212,326h and received 3,664,667 concurrent administrations. Concurrent infusions ran for 6,263,600h. There were 2,284,066 (62%) concurrent administrations; 334,144 (9%) were compatible, 293,856 (8%) were incompatible, 293,856 (8%) required pharmacist consultation, and 752,601 (21%) had 'unknown' compatibility. Individual patients received a median (IQR) of 33 (10-132) concurrent administrations, comprised of 7 (1-30) concurrent injections 1 (0-5) concurrent infusions and 13 (0-74) concurrently administered injections and infusions.
Conclusions:
Concurrent IV-drug administration is frequent in critically ill children. Known incompatible concurrent administration occurs, however the compatibilities of many drug-drug pairs were unknown - adding complexity to routine bedside management and identifying information gaps for future research.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Interval and Administration Route: Determination Methods
Factors Affecting Drug Response: Overview
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

